Home> Products> prescription only diabetes combination therapy

{ "products": [ { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH LINA 25/5", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 345.0, "discountamount": 104.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2025-08-04T12:40:52.619Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin and Linagliptin Tablets", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68822dd35b399ba6097ed11b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET G 0.5 FORTE", "description": "SEIZMET G0.5 FORTE is a powerful oral antidiabetic medication formulated with a combination of glimepiride and metformin hydrochloride. This dual-action therapy is specifically designed for patients with type 2 diabetes mellitus who are unable to control their blood sugar levels with diet and exercise alone. The combination works in synergy to manage blood glucose effectively, reduce insulin resistance, and improve overall glycemic control.\n\nGlimepiride and metformin hydrochloride tablets are a combination medication used to treat type 2 diabetes. They work by helping the pancreas release more insulin and by reducing the amount of sugar produced by the liver, while also making the body more sensitive to insulin.\n\nWhat is SEIZMET G0.5 FORTE?\nSEIZMET G0.5 FORTE contains two active ingredients:\n\nGlimepiride (0.5 mg): A sulfonylurea class drug that stimulates the beta cells of the pancreas to release insulin.\n\nMetformin Hydrochloride: A biguanide that works primarily by suppressing hepatic glucose production and increasing insulin sensitivity in muscles.\n\nTogether, this combination addresses both insulin deficiency and resistance—two key factors in type 2 diabetes.\n\nUses of SEIZMET G0.5 FORTE:\n\nEffective in managing type 2 diabetes mellitus\n\nHelps in reducing fasting and postprandial blood glucose levels\n\nUsed as monotherapy or in combination with other antidiabetic agents\n\nReduces the risk of diabetic complications such as nephropathy, retinopathy, and cardiovascular disease\n\nSide Effects of SEIZMET G0.5 FORTE:\nLike all medications, glimepiride and metformin hydrochloride tablets may cause side effects in some patients. Common side effects include:\n\nNausea or vomiting\n\nDiarrhea\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness\n\nMetallic taste in the mouth\n\nAbdominal discomfort\n\nIn rare cases, it may cause lactic acidosis, a serious condition related to metformin accumulation.\n\nPrecautions Before Using SEIZMET G0.5 FORTE:\n\nAlways take the medication exactly as prescribed by your doctor.\n\nInform your physician if you have a history of liver or kidney disorders, heart disease, or alcohol abuse.\n\nAvoid excessive alcohol consumption while on this medication as it increases the risk of lactic acidosis.\n\nNot recommended for patients with type 1 diabetes or diabetic ketoacidosis.\n\nRegularly monitor your blood sugar and kidney function.\n\nThis medicine should be used during pregnancy only if absolutely necessary and under medical supervision.\n\nDrug Interactions: What Drugs Interact with SEIZMET G0.5 FORTE?\nCertain medications can interact with glimepiride and metformin, affecting their efficacy or increasing the risk of side effects. These include:\n\nBeta-blockers (e.g., propranolol) – may mask hypoglycemia symptoms\n\nDiuretics – may impair blood sugar control\n\nACE inhibitors – may increase the blood glucose-lowering effect\n\nCorticosteroids – may reduce the effectiveness of the medication\n\nAntipsychotics (e.g., olanzapine)\n\nAlcohol – increases the risk of lactic acidosis\n\nCimetidine – may raise metformin levels in the body\n\nAlways inform your healthcare provider about all medications, supplements, or herbal products you are taking.\n\nConclusion:\nSEIZMET G0.5 FORTE is a trusted, effective choice for managing type 2 diabetes, offering the combined benefits of glimepiride and metformin hydrochloride tablets. With dual mechanisms—enhancing insulin secretion and improving insulin sensitivity—it delivers comprehensive glycemic control. When taken as directed and with regular monitoring, SEIZMET G0.5 FORTE can be a valuable part of a diabetic patient’s treatment regimen, contributing to a healthier, more balanced life.\n\nFor best results, pair this medication with a proper diet, regular physical activity, and periodic blood glucose testing. Always consult your healthcare provider for personalized advice.", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2151, "imageuri": "https://productimages.withfloats.com/actual/68822dd8296c4d19d55e8535.png", "tileimageuri": "https://productimages.withfloats.com/tile/68822dd8296c4d19d55e8535.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-24T12:57:55.385Z", "updatedon": "2025-07-24T12:57:55.385Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-g-0-5-forte/2151", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "glimepiride and metformin hydrochloride tablets", "category": "DIABETIC RANGE", "tags": [ "glimepiride and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6863d70eaf0c9d1aa0c2d3e5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLUTICATONE VILO 200", "description": "FLUTICATONE VILO 200 is a combination inhalation therapy containing Fluticasone Furoate (200 mcg), a potent corticosteroid, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA). This fixed-dose inhalation powder is specially formulated to manage and prevent symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma, helping patients breathe more easily and maintain better lung function.\n\nThis combination works synergistically—Fluticasone Furoate reduces inflammation and swelling in the airways, while Vilanterol relaxes the airway muscles, offering long-lasting bronchodilation. The once-daily dosing improves compliance and ensures consistent therapeutic effects throughout the day.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription combination medication used for long-term maintenance treatment of asthma and COPD. It is not a rescue medicine and should not be used to relieve sudden breathing problems.\n\nFluticasone Furoate 200 mcg: A highly effective corticosteroid that helps to reduce inflammation in the lungs.\n\nVilanterol 25 mcg: A bronchodilator that keeps airways open by relaxing muscles around them for up to 24 hours.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term treatment of moderate to severe asthma in adults and adolescents.\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.\n\nReduces the frequency of asthma attacks and COPD exacerbations.\n\nImproves overall lung function, quality of life, and exercise capacity in chronic airway diseases.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation uses\n\nSide Effects of Fluticasone Furoate and Vilanterol Powder for Inhalation\nWhile FLUTICATONE VILO 200 is generally well-tolerated, it may cause some side effects in certain individuals, especially during the initial phase of therapy. Common and less frequent side effects may include:\n\nHeadache\n\nHoarseness or voice changes\n\nSore throat\n\nCough or throat irritation\n\nFungal infection in the mouth (oral thrush)\n\nIncreased heart rate or palpitations\n\nMuscle cramps\n\nDizziness\n\nRespiratory tract infections\n\nSerious but rare effects include allergic reactions, paradoxical bronchospasm, and increased risk of pneumonia in COPD patients.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation side effects\n\nPrecautions Before Using\nDo not use FLUTICATONE VILO 200 for acute asthma or COPD attacks. Always carry a fast-acting inhaler.\n\nInform your doctor if you have a history of heart disease, hypertension, thyroid problems, liver disorders, or tuberculosis.\n\nRinse your mouth after each use to avoid oral thrush.\n\nUse the inhaler as prescribed, and do not exceed the recommended dose.\n\nNot recommended for use in children under 12 years unless prescribed.\n\nInform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.\n\nDrug Interactions\nCertain medications may affect the way FLUTICATONE VILO 200 works or increase the risk of side effects. Consult your doctor if you are taking:\n\nBeta-blockers (e.g., atenolol, propranolol)\n\nDiuretics (may increase the risk of hypokalemia)\n\nMAO inhibitors or tricyclic antidepressants (can enhance the effect of Vilanterol)\n\nAntifungal or antiviral medications (e.g., ketoconazole, ritonavir) that may increase corticosteroid levels\n\nOther long-acting beta agonists (LABAs) or inhaled corticosteroids\n\nWhat drugs interact with Fluticasone Furoate and Vilanterol?\nFluticasone Furoate and Vilanterol may interact with:\n\nStrong CYP3A4 inhibitors (like ritonavir, itraconazole) leading to increased steroid effects\n\nBeta-adrenergic blockers which may reduce the efficacy of vilanterol\n\nXanthine derivatives, diuretics, or digoxin, which may lead to heart rhythm disturbances when combined\n\nConclusion\nFLUTICATONE VILO 200 offers an effective, once-daily treatment for asthma and COPD by combining the anti-inflammatory power of Fluticasone Furoate 200 mcg and the long-acting bronchodilation of Vilanterol 25 mcg. It not only helps maintain clear airways but also improves your overall breathing comfort and quality of life. For optimal results, use the inhaler consistently and under your healthcare provider’s guidance.", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "12 years", "24 hours", "increased risk", "drugs interact", "antiviral medications", "recommended dose", "airways open", "reduce inflammation", "acute asthma", "asthma attacks", "severe asthma", "copd attacks", "inhaler consistently", "optimal results", "breathing comfort", "longacting bronchodilation", "antiinflammatory power", "inhaled corticosteroids", "vilanterol antifungal", "tricyclic antidepressants", "taking betablockers", "prescribed inform", "tuberculosis rinse", "headache hoarseness", "initial phase", "generally welltolerated", "fluticatone vilo 200", "exercise capacity", "emphysema reduces", "chronic bronchitis", "relaxing muscles", "rescue medicine", "vilanterol relaxes", "prevent symptoms", "specially formulated", "vilanterol 25 mcg", "vilanterol powder", "rare effects", "ketoconazole ritonavir", "healthcare provider", "therapy common", "potent corticosteroid", "fluticasone furoate", "side effects", "lung function", "vilanterol fluticasone furoate", "copd exacerbations improves", "inhalation fluticasone furoate", "lung function quality", "fixeddose inhalation powder", "increase corticosteroid levels", "fastacting inhaler inform", "combination inhalation therapy", "side effects consult", "frequent side effects", "inhalation longterm treatment", "healthcare providers guidance", "ritonavir itraconazole leading", "highly effective corticosteroid", "effective oncedaily treatment", "heart rhythm disturbances", "strong cyp3a4 inhibitors", "hypokalemia mao inhibitors", "atenolol propranolol diuretics", "breastfeeding drug interactions", "pregnant planning pregnancy", "avoid oral thrush", "sore throat cough", "adolescents maintenance treatment", "longterm maintenance treatment", "prescription combination medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2140, "imageuri": "https://productimages.withfloats.com/actual/686785bc0500f068046215ba.png", "tileimageuri": "https://productimages.withfloats.com/tile/686785bc0500f068046215ba.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-01T12:39:42.59Z", "updatedon": "2025-07-04T07:41:47.804Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-vilo-200/2140", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "fluticasone furoate and vilanterol powder for inhalation", "category": "ASTHMARANGE", "tags": [ "fluticasone furoate and vilanterol powder for inhalation" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6863d2854c1970de3d96ebcd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLUTICATONE VILO 100", "description": "FLUTICATONE VILO 100 is a combination inhalation therapy designed to manage and control chronic respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). This formulation contains two powerful agents: Fluticasone Furoate (100 mcg), a corticosteroid that reduces inflammation in the airways, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA) that helps in bronchodilation by relaxing airway muscles. Together, they provide long-term relief from symptoms like wheezing, shortness of breath, and chest tightness.\n\nThis powder is administered via inhalation, allowing targeted action directly at the site of inflammation and constriction, making it an effective and fast-acting treatment choice for those suffering from persistent asthma or airflow obstruction in COPD.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription medication used for long-term maintenance treatment of asthma and COPD in adults and adolescents. Fluticasone furoate is a synthetic corticosteroid that controls inflammation and swelling in the lungs. Vilanterol is a bronchodilator that improves breathing by relaxing muscles around the airways. The combination is not intended for acute bronchospasm relief but is ideal for daily use to manage chronic symptoms and prevent flare-ups.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term control of asthma symptoms such as wheezing, coughing, and breathlessness\n\nMaintenance treatment of COPD, including chronic bronchitis and emphysema\n\nPrevention of asthma exacerbations and hospitalizations\n\nImprovement in lung function and quality of life in chronic respiratory patients\n\nRegular use of this inhaler can help reduce dependency on rescue inhalers and lower the frequency of asthma attacks or COPD exacerbations.\n\nFluticasone Furoate and Vilanterol Powder for Inhalation Side Effects\nWhile generally well-tolerated, some users may experience mild to moderate side effects including:\n\nHeadache\n\nThroat irritation\n\nHoarseness of voice\n\nOral thrush (fungal infection in the mouth)\n\nCough or upper respiratory tract infections\n\nIncreased heart rate or palpitations\n\nMuscle cramps or tremors\n\nRare allergic reactions like rash, itching, or swelling\n\nTo minimize the risk of oral thrush, it is advised to rinse the mouth thoroughly after each inhalation.\n\nPrecautions Before Using FLUTICATONE VILO 100\nDo not use it to treat sudden asthma attacks; it is not a rescue inhaler.\n\nInform your doctor if you have a history of heart disease, high blood pressure, diabetes, or liver problems.\n\nUse with caution in pregnancy and breastfeeding; consult your physician.\n\nRegular monitoring of lung function and adrenal activity is recommended during long-term use.\n\nChildren and adolescents may require special dose adjustments under medical supervision.\n\nDrug Interactions: What Drugs Interact with Fluticasone Furoate and Vilanterol?\nSeveral medications may interact with this combination and alter its effectiveness or increase the risk of side effects:\n\nBeta-blockers (e.g., propranolol): May reduce the bronchodilatory effect of vilanterol\n\nKetoconazole or Ritonavir: These strong CYP3A4 inhibitors can increase the levels of fluticasone in the blood, raising the risk of side effects\n\nDiuretics: May increase the risk of hypokalemia when used with vilanterol\n\nOther corticosteroids: Concurrent use may enhance systemic corticosteroid side effects\n\nMAO inhibitors and Tricyclic Antidepressants: May amplify cardiovascular effects\n\nAlways inform your healthcare provider about any medications, supplements, or herbal products you are taking before starting FLUTICATONE VILO 100.\n\nConclusion\nFLUTICATONE VILO 100 is a scientifically advanced, dual-action inhalation therapy that provides effective long-term control for asthma and COPD. With the anti-inflammatory strength of fluticasone furoate 100 mcg and the bronchodilating effect of vilanterol 25 mcg, this combination ensures better breathing, fewer flare-ups, and improved quality of life. It’s a reliable and essential component in the chronic respiratory care of patients who need consistent symptom control and lung function improvement.", "price": 525.0, "discountamount": 158.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "combination ensures", "improved quality", "medications supplements", "drugs interact", "mouth cough", "reduce dependency", "synthetic corticosteroid", "asthma attacks", "asthma exacerbations", "asthma symptoms", "persistent asthma", "vilanterol powder", "controls inflammation", "reduces inflammation", "vilanterol ketoconazole", "lungs vilanterol", "vilanterol 25 mcg", "essential component", "bronchodilating effect", "antiinflammatory strength", "herbal products", "healthcare provider", "tricyclic antidepressants", "corticosteroids concurrent", "blood raising", "bronchodilatory effect", "adrenal activity", "breastfeeding consult", "liver problems", "fluticatone vilo 100", "oral thrush", "rash itching", "experience mild", "generally welltolerated", "emphysema prevention", "wheezing coughing", "prescription medication", "airflow obstruction", "constriction making", "chest tightness", "wheezing shortness", "inhalation precautions", "rescue inhalers", "hospitalizations improvement", "prevent flareups", "improves breathing", "fluticasone furoate", "chronic bronchitis", "lung function", "relaxing muscles", "rescue inhaler inform", "adolescents fluticasone furoate", "manage chronic symptoms", "inhalation fluticasone furoate", "lung function improvement", "effective longterm control", "breathing fewer flareups", "inhalation longterm control", "relaxing airway muscles", "inhalation side effects", "longterm maintenance treatment", "provide longterm relief", "chronic respiratory care", "consistent symptom control", "amplify cardiovascular effects", "side effects diuretics", "strong cyp3a4 inhibitors", "side effects betablockers", "physician regular monitoring", "palpitations muscle cramps", "moderate side effects", "breathlessness maintenance treatment", "acute bronchospasm relief", "fastacting treatment choice" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2139, "imageuri": "https://productimages.withfloats.com/actual/6863d28eeb66715cb5e18de8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6863d28eeb66715cb5e18de8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-01T12:20:21.253Z", "updatedon": "2025-07-01T12:28:46.31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-vilo-100/2139", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "fluticasone furoate and vilanterol powder for inhalation", "category": "ASTHMARANGE", "tags": [ "fluticasone furoate and vilanterol powder for inhalation" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662ca65a743fd235822236b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ABIRASTERON 250", "description": "ABIRASTERON 250\nAbiraterone Acetate lp (250mg)\nAbiraterone 250 is a medication containing Abiraterone Acetate LP in a strength of 250mg. Abiraterone Acetate is a potent inhibitor of androgen biosynthesis, specifically targeting the enzyme CYP17A1, which plays a crucial role in androgen production in the testes, adrenal glands, and prostate tumor tissue. By inhibiting this enzyme, Abiraterone Acetate suppresses the production of androgens like testosterone, which fuels the growth of prostate cancer cells.\n\nThis medication is primarily used in the treatment of metastatic castration-resistant prostate cancer (mCRPC), where the cancer has spread beyond the prostate gland and is resistant to hormone therapy. Abiraterone 250 is often prescribed in combination with other medications like prednisone or prednisolone to enhance its therapeutic effects.\n\nIt is important to take Abirasteron 250 exactly as prescribed by your healthcare provider. Typically, it is taken on an empty stomach, at least one hour before or two hours after eating. The dosage and duration of treatment will be determined by your doctor based on your medical condition, response to treatment, and other medications you may be taking.\n\nCommon side effects of Abirasteron 250 may include fatigue, joint pain, high blood pressure, fluid retention, hot flashes, and gastrointestinal disturbances like diarrhea or nausea. It's important to report any unusual or severe side effects to your doctor promptly.\n\nAbiraterone 250 is a prescription medication and should only be used under the guidance and supervision of a healthcare professional.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/abirasteron-250-133650", "price": 39000.0, "discountamount": 11700.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "250mg", "Order", "Email", "mCRPC", "testes", "growth", "doctor", "nausea", "dosage", "fatigue", "unusual", "diarrhea", "response", "guidance", "duration", "strength", "WhatsApp", "androgens", "treatment", "joint pain", "prednisone", "hot flashes", "combination", "information", "supervision", "ABIRASTERON", "testosterone", "sterispharma", "prednisolone", "sterisonline", "crucial role", "enzyme CYP17A", "empty stomach", "adrenal glands", "prostate gland", "fluid retention", "hormone therapy", "potent inhibitor", "medical condition", "other medications", "high blood pressure", "Common side effects", "severe side effects", "therapeutic effects", "androgen production", "healthcare provider", "prostate cancer cells", "prostate tumor tissue", "androgen biosynthesis", "Abiraterone Acetate LP", "prescription medication", "healthcare professional", "gastrointestinal disturbances", "metastatic castration-resistant prostate cancer" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1516, "imageuri": "https://productimages.withfloats.com/actual/667d334f6c582d228f45a9d8.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d334f6c582d228f45a9d8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:52:53.718Z", "updatedon": "2024-06-27T09:39:24.479Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/abirasteron-250/1516", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ABIRASTERON 250", "category": "GENERAL RANGE", "tags": [ "abiraterone acetate 250 mg brands in india", "abiraterone acetate 250 mg brands in india", "abiraterone acetate side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665eef7e4515df174861ed41", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIBEMIDE FORTE ", "description": "GLIBEMIDE FORTE \nGlibenclamide (5mg), Metformin HCI (500mg)\nGLIBEMIDE FORTE is a combination medication containing two active ingredients: Glibenclamide (5mg) and Metformin HCI (500mg). This combination is formulated to offer dual-action glucose-lowering therapy for the management of type 2 diabetes mellitus.\n\nGlibenclamide, also known as glyburide, belongs to the sulfonylurea class of medications. It works by stimulating the release of insulin from the pancreatic beta cells, thereby increasing insulin secretion. This helps lower blood glucose levels by promoting the uptake of glucose into cells and reducing hepatic glucose production.\n\nMetformin HCI is a biguanide medication that primarily works by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues, such as muscle and fat. It also reduces intestinal absorption of glucose, leading to lower postprandial glucose levels.\n\nBy combining Glibenclamide and Metformin HCI, GLIBEMIDE FORTE addresses multiple pathophysiological defects underlying type 2 diabetes. Glibenclamide stimulates insulin secretion, while Metformin HCI reduces insulin resistance and hepatic glucose output, resulting in improved glycemic control.\n\nGLIBEMIDE FORTE is indicated for the treatment of type 2 diabetes mellitus in adults, particularly for patients whose blood sugar levels are not adequately controlled with either Glibenclamide or Metformin HCI alone. This combination medication offers the convenience of fixed-dose therapy, simplifying the treatment regimen for patients with diabetes.\n\nAs with any medication, GLIBEMIDE FORTE may cause side effects, including hypoglycemia, gastrointestinal disturbances such as nausea, vomiting, or diarrhea, and rarely, allergic reactions. Patients should be monitored regularly for these adverse effects, and dosage adjustments may be necessary based on individual response and tolerability.\n\nOverall, GLIBEMIDE FORTE provides an effective and convenient option for the management of type 2 diabetes mellitus, offering dual-action glucose-lowering therapy with the combination of Glibenclamide and Metformin HCI. However, it should only be used under the supervision of a healthcare professional and as part of a comprehensive treatment plan that includes lifestyle modifications and regular monitoring of blood glucose levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glibemide-forte-133416\n\n\n", "price": 44.0, "discountamount": 13.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "fat", "part", "Order", "EMAIL", "uptake", "nausea", "muscle", "adults", "release", "diarrhea", "vomiting", "patients", "glyburide", "effective", "management", "medications", "convenience", "supervision", "information", "side effects", "hypoglycemia", "tolerability", "sterispharma", "sterisonline", "Metformin HCI", "CALL/WHATSAPP", "Glibenclamide", "GLIBEMIDE FORTE", "adverse effects", "glycemic control", "insulin secretion", "treatment regimen", "convenient option", "insulin resistance", "blood sugar levels", "fixed-dose therapy", "sulfonylurea class", "allergic reactions", "dosage adjustments", "peripheral tissues", "regular monitoring", "insulin sensitivity", "individual response", "biguanide medication", "blood glucose levels", "intestinal absorption", "pancreatic beta cells", "two active ingredients", "combination medication", "hepatic glucose output", "healthcare professional", "lifestyle modifications", "type 2 diabetes mellitus", "hepatic glucose production", "postprandial glucose levels", "comprehensive treatment plan", "gastrointestinal disturbances", "multiple pathophysiological defects", "dual-action glucose-lowering therapy" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1282, "imageuri": "https://productimages.withfloats.com/actual/665eef804f159c14e15f27b7.png", "tileimageuri": "https://productimages.withfloats.com/tile/665eef804f159c14e15f27b7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T10:42:06.137Z", "updatedon": "2024-06-04T10:42:06.137Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glibemide-forte-/1282", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIBEMIDE FORTE ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ed10e8da3a81d5c69dece", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DAPA VILDA 5/100 SR ", "description": "DAPA VILDA 5/100 SR \nDapagliflozin (5mg), Vildagliptin SR (100mg)\nDAPA VILDA 5/100 SR is a combination medication consisting of two active ingredients: Dapagliflozin (5mg) and Vildagliptin SR (100mg). Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, while Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor with sustained-release formulation.\n\nDapagliflozin works by inhibiting SGLT2 in the kidneys, thereby reducing glucose reabsorption and increasing urinary glucose excretion, leading to lower blood glucose levels. Vildagliptin, on the other hand, acts by inhibiting DPP-4 enzyme, which prolongs the action of incretin hormones like GLP-1 and GIP, enhancing insulin secretion and suppressing glucagon release, ultimately reducing blood glucose levels.\n\nThis combination medication is indicated for the management of type 2 diabetes mellitus in adults. By targeting different pathways involved in glucose metabolism, DAPA VILDA 5/100 SR offers a comprehensive approach to glycemic control, helping patients achieve and maintain target blood glucose levels. It is typically prescribed as an adjunct to diet and exercise in patients whose diabetes is not adequately controlled with monotherapy or as a dual therapy option for those who require additional glucose-lowering agents.\n\nAs with any medication, DAPA VILDA 5/100 SR may cause side effects, including but not limited to urinary tract infections, genital mycotic infections, hypoglycemia, and gastrointestinal disturbances. Patients should be monitored regularly for these adverse effects, and dosage adjustments may be necessary based on individual response and tolerability.\n\nOverall, DAPA VILDA 5/100 SR offers a convenient once-daily dosing option and a synergistic approach to managing type 2 diabetes, helping patients achieve better glycemic control and potentially reducing the risk of long-term complications associated with uncontrolled diabetes. However, it should only be used under the supervision of a healthcare professional and as part of a comprehensive diabetes management plan tailored to the individual patient's needs and goals.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/dapa-vilda-5-100-sr-134362", "price": 130.0, "discountamount": 39.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "risk", "part", "EMAIL", "goals", "needs", "Order", "GLP-1", "adults", "action", "target", "adjunct", "kidneys", "patients", "exercise", "other hand", "dapa-vilda", "convenient", "monotherapy", "information", "supervision", "hypoglycemia", "DPP-4 enzyme", "sterispharma", "side effects", "tolerability", "sterisonline", "CALL/WHATSAPP", "transporter 2", "Dapagliflozin", "sodium-glucose", "Vildagliptin SR", "adverse effects", "SGLT2) inhibitor", "glycemic control", "glucagon release", "DPP-4) inhibitor", "insulin secretion", "incretin hormones", "dosage adjustments", "individual patient", "different pathways", "glucose metabolism", "DAPA VILDA 5/100 SR", "individual response", "dual therapy option", "daily dosing option", "synergistic approach", "glucose reabsorption", "uncontrolled diabetes", "two active ingredients", "dipeptidyl peptidase-4", "comprehensive approach", "combination medication", "healthcare professional", "long-term complications", "urinary tract infections", "type 2 diabetes mellitus", "urinary glucose excretion", "genital mycotic infections", "lower blood glucose levels", "sustained-release formulation", "gastrointestinal disturbances", "additional glucose-lowering agents", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1274, "imageuri": "https://productimages.withfloats.com/actual/665ed12ffb1d1538612033fd.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ed12ffb1d1538612033fd.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T08:32:14.71Z", "updatedon": "2024-06-04T08:32:14.71Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/dapa-vilda-5-100-sr-/1274", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DAPA VILDA 5/100 SR ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "662f4992ab98b00ba41bae9e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PREGABRIAL 75 ", "description": "PREGABRIAL 75 \nPregabalin (75mg)\nPregabrial 75, containing 75mg of Pregabalin per capsule, is a prescription medication primarily used to manage neuropathic pain, which is pain arising from damaged nerves. This type of pain can be associated with conditions such as diabetes (diabetic neuropathy), spinal cord injury, or shingles (post-herpetic neuralgia). Additionally, Pregabrial 75 is effective in treating partial onset seizures in adults when taken in combination with other medications. It works by affecting chemicals in the brain that send pain signals across the nervous system.\n\nPregabalin is also commonly prescribed to address generalized anxiety disorder, offering relief from the symptoms of anxiety. It is essential for users to follow their healthcare provider's instructions closely, as the dosage may vary based on the condition being treated and the patient's overall health profile. Potential side effects include dizziness, drowsiness, dry mouth, and swelling in the hands and feet. Patients should inform their doctor of all medications they are currently taking to avoid adverse drug interactions. As with any medication, it is crucial to discuss any concerns or side effects experienced with a healthcare professional.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 295.0, "discountamount": 89.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "75mg", "feet", "type", "hands", "users", "brain", "doctor", "adults", "relief", "dosage", "nerves", "patient", "damaged", "capsule", "symptoms", "shingles", "diabetes", "swelling", "concerns", "dizziness", "dry mouth", "chemicals", "PREGABRIAL", "drowsiness", "conditions", "Pregabalin", "combination", "pain signals", "instructions", "nervous system", "neuropathic pain", "other medications", "spinal cord injury", "diabetic neuropathy", "healthcare provider", "Potential side effects", "overall health profile", "partial onset seizures", "healthcare professional", "post-herpetic neuralgia", "prescription medication", "adverse drug interactions", "generalized anxiety disorder" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 787, "imageuri": "https://productimages.withfloats.com/actual/662f4995481840e7a7feb0ea.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/662f4995481840e7a7feb0ea.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-29T07:17:38.571Z", "updatedon": "2024-06-12T12:47:23.914Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pregabrial-75-/787", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Pregabalin (75mg)", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }